Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) | PAR 21 175

FAQs: Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) (PAR-21-175; CFDA 93.242)

What is this NIH funding opportunity about?

This NIH R01 opportunity supports systems and translational neuroscience research that tests whether deliberately changing the timing patterns of coordinated brain activity can reliably improve cognition, emotion-related functioning, or social processing in living organisms. The emphasis is on intervention (changing neural dynamics in vivo) rather than only observing or correlating rhythms with behavior.

What makes a project a strong fit for this FOA?

Strong-fit projects move beyond correlation and directly test causality: they identify a specific temporal coordination feature, explain why it matters for a specific function, modify it using a well-justified approach, verify that the neural dynamic changed as intended, and show that the change produces measurable improvement in cognitive, affective, or social outcomes.

Is the goal to study neural rhythms, or to change them?

The FOA is aimed at research that actually modifies coordinated neural activity, not projects that only measure it. Observational work alone is not the central focus; proposals are expected to intervene in vivo and test causal links to function.

What kinds of neural activity patterns are in scope?

The FOA highlights electrophysiological and temporal coordination features such as oscillations, synchrony, coherence, phase relationships, cross-frequency coupling, and other temporal coordination properties across neural populations and brain regions.

What does "temporal dynamics of coordinated neural activity" mean in practical terms?

In practical terms, it refers to how the timing relationships among neural signals are organized across cells, populations, and regions (for example, rhythmic oscillatory timing, phase alignment, coordinated bursts, or coupling between frequency bands), and how those timing relationships influence communication and computation in neural circuits.

What is the core scientific question NIH wants applicants to test here?

The central question is whether deliberately changing the timing patterns of coordinated brain activity can causally and reliably improve cognition, affective functioning, or social processing in living organisms.

What does "move beyond correlation" mean for study design?

It means proposing experiments that directly test causality by manipulating a targeted temporal dynamic (rather than only associating it with behavior) and then evaluating whether that manipulation produces predicted changes in both neural coordination and functional outcomes.

What kind of rationale does NIH expect for the targeted rhythm or coordination pattern?

The FOA expects a clear, testable, mechanistic rationale explaining why the targeted temporal dynamic is functionally important. Applicants are encouraged to ground the intervention in a rational model describing how temporal dynamics route information, coordinate communication across circuits, or gate how incoming signals influence local computation.

Do projects need to connect neural dynamics to a theory of information flow or circuit function?

Yes. The FOA emphasizes that strong applications typically link a specific rhythm or coordination pattern to a mechanistic theory of information flow or circuit function, then test whether shifting that pattern changes cognition, affect, or social behavior as predicted.

Are animal studies allowed?

Yes. The FOA encourages studies in animals and/or humans, including animal work that uses invasive recordings and perturbations to modify electrophysiological activity patterns in vivo.

Are human studies allowed?

Yes. Human studies are in scope, including work using noninvasive recording and neuromodulation approaches, as long as the proposal targets and modifies coordinated neural activity and evaluates functional outcomes.

Can a project combine animal and human work?

Yes. The FOA explicitly allows hybrid translational pipelines, such as using a mechanistic discovery in animals to justify and design a targeted intervention study in humans.

What does "Clinical Trial Optional" mean for this R01?

It means the application may include a clinical trial if the research meets NIH's definition of a clinical trial, but a clinical trial is not required. Both non-clinical and clinical approaches can be supported under this FOA.

If a project includes a clinical trial, does it need to meet NIH's clinical trial definition?

Yes. The FOA notes that clinical trials may be included if the research question and design meet NIH's clinical trial definition.

What are the key elements NIH expects proposals to clearly explain?

The FOA describes four practical expectations: (1) what temporal dynamic is being targeted, (2) why that dynamic is functionally important for the tested domain (cognitive, affective, or social), (3) how it will be modified, and (4) what outcomes will demonstrate improvement.

What kinds of outcomes are appropriate for demonstrating improvement?

Typical outcomes mentioned include behavioral performance metrics, symptom-relevant readouts, or task-based indices of cognitive control, learning, memory, emotion processing, or social interaction, paired with neural evidence that the intended electrophysiological pattern was changed in the predicted direction.

Do applicants need to show that the neural dynamics were actually changed?

Yes. A central expectation is that the project confirms the targeted electrophysiological pattern was modified in the predicted direction, not just that an intervention was delivered.

Does this FOA focus on cognition only?

No. The FOA includes cognition, emotion-related functioning (affective regulation and related domains), and social processing as key functional areas where improvement may be tested.

What kinds of intervention approaches are acceptable?

The FOA allows a wide variety of electrophysiology-linked strategies, provided the proposal clearly describes the targeted temporal feature, the rationale for its functional role, the method for modifying it in vivo, and the outcome measures that will demonstrate improvement.

Is there a companion funding mechanism mentioned?

Yes. The announcement notes that a companion R21 is expected, indicating NIH interest in supporting both shorter exploratory/high-risk projects (R21) and larger, more definitive hypothesis-driven programs (R01). This R01 is positioned for deeper mechanistic testing and stronger outcome validation.

Who is eligible to apply?

Eligibility is broad and includes many organization types beyond traditional research universities. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status); for-profit organizations (other than small businesses) as well as small businesses; and other categories.

Does the FOA encourage applications from institutions serving underrepresented communities?

Yes. The FOA explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, HBCUs, and tribally controlled colleges and universities (TCCUs), along with faith-based or community-based organizations.

Are U.S. territories or possessions eligible?

Yes. The FOA includes regional organizations and U.S. territories or possessions among the highlighted eligible applicant categories.

Are non-U.S. (foreign) organizations eligible?

Yes. The FOA indicates that non-U.S. (foreign) organizations are eligible applicants.

Are federal agencies eligible to apply?

Yes. The FOA highlights eligible federal agencies among the additional eligible applicant types.

What is the mechanism and how is the opportunity categorized?

The mechanism is an NIH R01. Administratively, it is described as a discretionary grant mechanism under NIH.

What are the FOA identifier and CFDA number?

The FOA is PAR-21-175 and the CFDA number listed is 93.242.

What is the closing date listed in the provided information?

The listing includes an original closing date of January 7, 2025.

What is the creation date listed in the provided information?

The listing includes a creation date of March 18, 2021.

Does the provided information include an award ceiling or the expected number of awards?

No. The supplied source text does not provide an award ceiling or the expected number of awards. It notes that applicants typically need to consult the full FOA and NIH institute/center participation details for budget expectations, project period norms, and any institute-specific priorities or limits.

What is NIH signaling it wants to fund through this FOA, at a high level?

NIH is signaling interest in projects that form a tight loop between theory, measurement, intervention, and validated outcomes: identify a plausible temporal coordination bottleneck, change it with a targeted method, confirm the neural dynamic changed as intended, and demonstrate improved cognitive, affective, or social processing.